Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 1;151(5):e2022061146.
doi: 10.1542/peds.2022-061146.

SARS-CoV-2 During Omicron Variant Predominance Among Infants Born to People With SARS-CoV-2

Lucas Gosdin  1   2 , Daniel Chang  2   3 , Emily O'Malley Olsen  2 , Elizabeth L Lewis  2 , Heather Wingate  4 , Kristen D Ojo  5 , Hanna Shephard  6 , Ayomide Sokale  7 , Evan L Mobley  8 , Camille Delgado-López  9 , Aron J Hall  2 , Suzanne M Gilboa  2 , Van T Tong  2 , Kate R Woodworth  2
Affiliations

SARS-CoV-2 During Omicron Variant Predominance Among Infants Born to People With SARS-CoV-2

Lucas Gosdin et al. Pediatrics. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST DISCLOSURE: The authors have indicated they have no potential conflicts of interest to disclose. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the U.S. Centers for Disease Control and Prevention.

Figures

FIGURE 1
FIGURE 1
Timing of first positive SARS-CoV-2 testing among infants aged 0 to 6 months born to people with SARS-CoV-2 infections during pregnancy compared with national case incidence among children aged 0 to 4 years: 6 SET-NET jurisdictions, March 2020–September 2022. aNumber of infants with first positive polymerase chain reaction SARS-CoV-2 laboratory test during their first 6 months of age, weighted. bCenters for Disease Control and Prevention, COVID-19 response. COVID-19 case surveillance public use data with geography (version date: November 03, 2022).
See this image and copyright information in PMC

References

    1. Walensky RP, Walke HT, Fauci AS. SARS-CoV-2 variants of concern in the United States—challenges and opportunities. JAMA. 2021;325(11):1037–1038 - PMC - PubMed
    1. Bálint G, Vörös-Horváth B, Széchenyi A. Omicron: increased transmissibility and decreased pathogenicity. Signal Transduct Target Ther. 2022;7(1):151. - PMC - PubMed
    1. Iuliano AD, Brunkard JM, Boehmer TK, et al. Trends in disease severity and health care utilization during the early omicron variant period compared with previous SARS-CoV-2 high transmission periods - United States, December 2020-January 2022. MMWR Morb Mortal Wkly Rep. 2022;71(4):146–152 - PMC - PubMed
    1. Marks KJ, Whitaker M, Agathis NT, et al.; COVID-NET Surveillance Team. Hospitalization of infants and children aged 0–4 years with laboratory-confirmed COVID-19 - COVID-NET, 14 states, March 2020-February 2022. MMWR Morb Mortal Wkly Rep. 2022;71(11):429–436 - PMC - PubMed
    1. Hamid S, Woodworth K, Pham H, et al.; COVID-NET Surveillance Team. COVID-19-associated hospitalizations among U.S. infants aged <6 months - COVID-NET, 13 states, June 2021-August 2022. MMWR Morb Mortal Wkly Rep. 2022;71(45):1442–1448 - PMC - PubMed

Publication types

Supplementary concepts